Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lifecyn is a privately owned Greek consumer healthcare company specializing in innovative, science-based antiseptic and wound care solutions. Headquartered in Athens, the company has extensive experience in the Greek and European markets, maintaining a distribution capacity that covers the entire country. Lifecyn is the exclusive distributor for Bactiguard's Hydrocyn aqua product range in Greece, which includes non-alcoholic, pH-neutral solutions for advanced disinfection and wound healing. The company focuses on high-quality healthcare lines that promote safety, healing, and personal wellbeing for consumers. Its flagship product, Hydrocyn aqua, is a hypochlorous acid-based solution proven effective against a broad spectrum of pathogens, including SARS-CoV-2.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lifecyn.